TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy

Cellular energy metabolism not only promotes tumor cell growth and metastasis but also directs immune cell survival, proliferation and the ability to perform specific and functional immune responses within the tumor microenvironment. A better understanding of the molecular regulation of metabolism in different cell components in the tumor-suppressive microenvironment is critical for the development of effective strategies for human cancer treatments. Toll-like receptors (TLRs) have recently been recognized as critical factors involved in tumor pathogenesis, regulating both tumor cells and tumor-infiltrating innate and adaptive immune cells. However, little is known about the molecular crosstalk between TLR signaling and tumor or/and immune cell metabolism, although there is abundant expression of TLRs in these cells. In this review, we explore the functional role of TLR signaling in reprogramming cell metabolism in the tumor microenvironment. In particular, we discuss how malignant tumors regulate metabolism to support their growth and survival, summarize more recently identified metabolic profiles of different immune cell subsets and TLR-mediated regulation of cellular metabolism in both tumor and immune cells, and further explore potential strategies targeting cell metabolism for TLR-based cancer therapy. An improved understanding of these issues should open new avenues for the development of novel strategies via TLR-mediated metabolic reprogramming of the tumor microenvironment for cancer immunotherapy.

• Publication year

  2018

• Venue

  Cellular & Molecular Immunology

• Publication date

  2018-03-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/cmi.2018.4PMID 29553135PMCID 6068099
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor

  2017cited by this paper
• Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy

  2017cited by this paper
• Metabolic Interactions in the Tumor Microenvironment.

  2017cited by this paper
• Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions

  2017cited by this paper
• Metabolism shapes the tumor microenvironment.

  2017cited by this paper
• Succinate is an inflammatory signal that induces IL-1 beta through HIF-1 alpha

  2017cited by this paper
• Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.

  2017cited by this paper
• TLR7 Signaling Regulates Th17 Cells and Autoimmunity: Novel Potential for Autoimmune Therapy

  2017cited by this paper
• Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity

  2017cited by this paper
• Foxp3 and Toll-Like Receptor Signaling Balance Treg Cell Anabolic Metabolism for Suppression

  2017cited by this paper
• Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity

  2017cited by this paper
• Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities

  2016cited by this paper
• The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements

  2016cited by this paper
• Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis.

  2016cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming.

  2016cited by this paper
• Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer

  2016cited by this paper
• Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells

  2016cited by this paper
• TLR-Mediated Innate Production of IFN-γ by CD8+ T Cells Is Independent of Glycolysis

  2016cited by this paper
• Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function.

  2016cited by this paper
• Immunometabolism of regulatory T cells

  2016cited by this paper
• LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

  2016cited by this paper
• Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression

  2016cited by this paper
• Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma

  2016cited by this paper
• The Warburg Effect: How Does it Benefit Cancer Cells?

  2016cited by this paper
• Lipid metabolic reprogramming in cancer cells

  2016cited by this paper
• Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance

  2016cited by this paper
• Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages

  2016cited by this paper
• Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells

  2016cited by this paper
• Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes

  2016cited by this paper
• Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization.

  2015cited by this paper
• Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

  2015cited by this paper
• Nutrient Competition: A New Axis of Tumor Immunosuppression.

  2015cited by this paper
• Targeting T cell metabolism for therapy.

  2015cited by this paper
• Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs.

  2015cited by this paper
• Correlation of serum toll like receptor 9 and trace elements with lipid peroxidation in the patients of breast diseases.

  2015cited by this paper
• Metabolic control of regulatory T cell development and function.

  2015cited by this paper
• Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis

  2015cited by this paper
• Metabolic reprogramming in macrophages and dendritic cells in innate immunity

  2015cited by this paper
• Inhibition of indoleamine 2,3‐dioxygenase activity enhances the anti‐tumour effects of a Toll‐like receptor 7 agonist in an established cancer model

  2015cited by this paper
• Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

  2015cited by this paper
• IL-10 Production in Macrophages Is Regulated by a TLR-Driven CREB-Mediated Mechanism That Is Linked to Genes Involved in Cell Metabolism

  2015cited by this paper
• Controlling T cell senescence in the tumor microenvironment for tumor immunotherapy

  2015cited by this paper
• Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants

  2015cited by this paper
• Radiation-driven lipid accumulation and dendritic cell dysfunction in cancer

  2015cited by this paper
• The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2

  2014cited by this paper
• Macrophage activation and polarization: nomenclature and experimental guidelines.

  2014cited by this paper
• The exploitation of Toll-like receptor 3 signaling in cancer therapy.

  2014cited by this paper
• TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence

  2014cited by this paper
• De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells

  2014cited by this paper
• Metabolic Influences That Regulate Dendritic Cell Function in Tumors

  2014cited by this paper
• Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer

  2014cited by this paper
• The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function.

  2014cited by this paper
• Functional polarization of tumour-associated macrophages by tumour-derived lactic acid

  2014cited by this paper
• Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation

  2014cited by this paper
• Metabolic Control of Dendritic Cell Activation and Function: Recent Advances and Clinical Implications

  2014cited by this paper
• TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation

  2014cited by this paper
• Metabolic regulation of T lymphocytes.

  2013cited by this paper
• Metabolic Reprogramming and Validation of Hyperpolarized 13C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor

  2013cited by this paper
• Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.

  2013cited by this paper
• Abstract 4995: Tumor-dervied gammadelta regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.

  2013cited by this paper
• mTORC1 couples immune signals and metabolic programming to establish Treg cell function

  2013cited by this paper
• Succinate is an inflammatory signal that induces IL-1β through HIF-1α

  2013cited by this paper
• Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation

  2013cited by this paper
• Molecular Pathways Molecular Pathways : Toll-like Receptors in the Tumor Microenvironment — Poor Prognosis or New Therapeutic Opportunity

  2013cited by this paper
• Differential Involvement of Th1 and Th17 in Pathogenic Autoimmune Processes Triggered by Different TLR Ligands

  2013cited by this paper
• The TSC-mTOR pathway regulates macrophage polarization

  2013cited by this paper
• Tumor-Derived γδ Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence

  2013cited by this paper
• Posttranscriptional control of T cell effector function by aerobic glycolysis.

  2013cited by this paper
• Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

  2013cited by this paper
• Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose

  2013cited by this paper
• Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.

  2013cited by this paper
• Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells.

  2012cited by this paper
• Anticancer TLR agonists on the ropes

  2012cited by this paper
• Validation of Hyperpolarized 13 C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor

  2012cited by this paper
• The tumor microenvironment.

  2012cited by this paper
• Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T‐cell‐mediated immunity

  2012cited by this paper
• Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation

  2012cited by this paper
• Differential protein pathways in 1,25-dihydroxyvitamin d(3) and dexamethasone modulated tolerogenic human dendritic cells.

  2012cited by this paper
• Human regulatory T cells induce T-lymphocyte senescence.

  2012cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1.

  2012cited by this paper
• STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation.

  2012cited by this paper
• HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

  2011cited by this paper
• Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets

  2011cited by this paper
• Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5.

  2011cited by this paper
• Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

  2011cited by this paper
• Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma.

  2011cited by this paper
• The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

  2011cited by this paper
• Identification of IDO-Positive and IDO-Negative Human Dendritic Cells after Activation by Various Proinflammatory Stimuli

  2011cited by this paper
• How tolerogenic dendritic cells induce regulatory T cells.

  2010cited by this paper
• The tumor microenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker

  2010cited by this paper
• Programming dendritic cells to induce TH2 and tolerogenic responses

  2010cited by this paper
• Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.

  2010cited by this paper
• Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease.

  2010cited by this paper
• High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer

  2010cited by this paper
• Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.

  2010cited by this paper
• Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation.

  2010cited by this paper
• Metabolism in T cell activation and differentiation.

  2010cited by this paper
• Enhancing CD 8 T Cell Memory by Modulating Fatty Acid Metabolism

  2010cited by this paper

• Dysregulated Energy Homeostasis at the Crossroads of Cancer-Depression Comorbidity: A Brain-Body-Tumor Interaction Perspective.

  2026cites this paper
• ICIsc: A Deep Learning Framework for Predicting Immune Checkpoint Inhibitor Response by Integrating scRNA-Seq and Protein Language Models.

  2026cites this paper
• TIR domain proteins: regulatory mechanisms in the tumor immune microenvironment, clinical translation strategies, and prospects for precision therapy applications

  2025cites this paper
• Organoid: a promising solution to current challenges in cancer immunotherapy

  2025cites this paper
• Sex-specific mechanisms in the pathogenesis and progression of chronic kidney disease.

  2025cites this paper
• Imidazoloquinoline optical isomers as TLR7 selective agonists promote macrophage activation for cancer immunotherapy.

  2025cites this paper
• Characterization of a Hydrogel Composite Containing Bioactive Moringa as a Novel Pulp-Capping Material

  2025cites this paper
• Emerging mechanisms of triple-negative breast cancer radioresistance: Interplay between cancer cell mechanisms and the tumor immune microenvironment.

  2025cites this paper
• Profiling of immune cell subsets and functional characteristics of cervical cancer based on single cell RNA sequencing

  2025cites this paper
• Surgery-Induced Neutrophil Extracellular Traps Promote Tumor Metastasis by Reprogramming Cancer Cell Lipid Metabolism.

  2025cites this paper
• Mitochondrial Homeostasis in Cancer: Functions and Targeted Therapies.

  2025cites this paper
• Unraveling the connection: M2 macrophage polarization and cancer metabolism

  2025cites this paper
• Metabolic Reprogramming of Tumors: Induced Immunosuppression and Therapeutic Prospects of Nanoscale Drug Delivery Systems.

  2025cites this paper
• Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation.

  2025cites this paper
• Programmed Death Ligand 1 Modulation by Bacillus Calmette-Guérin and Toll-Like Receptor Agonists in Distinct Breast Cancer Cell Subtypes

  2025cites this paper
• Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value.

  2025cites this paper
• The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities

  2025cites this paper
• Toll-like Receptor Activation Remodels the Polyamine and Tryptophan Metabolism in Porcine Macrophages

  2025cites this paper
• An Enzyme-Responsive Imiquimod Prodrug for Precision Immune Activation within the Tumor Microenvironment.

  2025cites this paper
• E3 Ubiquitin Ligase RNF13 Suppresses TLR Lysosomal Degradation by Promoting LAMP‐1 Proteasomal Degradation

  2024cites this paper
• Sex differences in disease: sex chromosome and immunity

  2024cites this paper
• Immunotherapy in gastrointestinal cancers: current strategies and future directions – a literature review

  2024cites this paper
• Current status and future prospects of combined immunotherapy and epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma.

  2024cites this paper
• Implication of Toll-Like Receptors in growth and management of health and diseases: Special focus as a promising druggable target to Prostate Cancer.

  2024cites this paper
• Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells.

  2024cites this paper
• Targeting inflammation with hyaluronic acid-based micro- and nanotechnology: A disease-oriented review.

  2024cites this paper
• Dual and multi-immune activation strategies for emerging cancer immunotherapy

  2024cites this paper
• Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy

  2024cites this paper
• IRnet: Immunotherapy response prediction using pathway knowledge-informed graph neural network

  2024cites this paper
• Investigating the Immune-Stimulating Potential of β-Glucan from Aureobasidium pullulans in Cancer Immunotherapy

  2024cites this paper
• Sex as a Biological Variable in Early-Phase Oncology Clinical Trials: Enhancing the Path to Personalised Medicine

  2024cites this paper
• Immunoexpression pattern of TLR3 and TLR7 in minor salivary gland adenoid cystic carcinoma and its role in prognosis.

  2024cites this paper
• Regulatory mechanisms of PD-1/PD-L1 in cancers

  2024cites this paper
• Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation.

  2024cites this paper
• Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma

  2024cites this paper
• Palmitic acid combined with γ-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages’ polarization via the TLR4 pathway

  2023cites this paper
• Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy

  2023cites this paper
• Toll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy

  2023cites this paper
• Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives

  2023cites this paper
• Engineering the glioblastoma microenvironment using TLR7/8 agonist-complexed graphene oxide nanosheets

  2023cites this paper
• Molecular characteristics and therapeutic implications of Toll-like receptor signaling pathway in melanoma

  2023cites this paper
• Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance

  2023cites this paper
• NOS inhibition reverses TLR2-induced chondrocyte dysfunction and attenuates age-related osteoarthritis

  2023cites this paper
• Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene

  2023cites this paper
• Polymeric microneedles enable simultaneous delivery of cancer immunomodulatory drugs and detection of skin biomarkers

  2023cites this paper
• Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

  2023cites this paper
• Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration‐resistant prostate cancer

  2023cites this paper
• Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment

  2023cites this paper
• Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer

  2023cites this paper
• Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang

  2022cites this paper
• (Im)maturity in Tumor Ecosystem

  2022cites this paper
• Toll-Like Receptors (TLRs) in Health and Disease: An Overview.

  2022cites this paper
• Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.

  2022cites this paper
• Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

  2022cites this paper
• TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma

  2022cites this paper
• Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands

  2022cites this paper
• Context-dependent functions of pattern recognition receptors in cancer

  2022cites this paper
• Targeting Oncometabolism to Maximize Immunotherapy in Malignant Brain Tumors

  2022cites this paper
• Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and Neutrophils

  2022cites this paper
• Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis

  2022cites this paper
• Qin Huang formula enhances the effect of Adriamycin in B-cell lymphoma via increasing tumor infiltrating lymphocytes by targeting toll-like receptor signaling pathway

  2022cites this paper
• Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma

  2022cites this paper
• Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity

  2022cites this paper
• Therapeutic applications of toll-like receptors (TLRs) agonists in AML

  2022cites this paper
• Targeting macrophages in hematological malignancies: recent advances and future directions

  2022cites this paper
• Research advances in nanomedicine applied to the systemic treatment of colorectal cancer

  2022cites this paper
• Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide

  2022cites this paper
• Polymeric microneedle-based platform enables simultaneous delivery of cancer immunomodulatory drugs and detection of biomarkers in the skin

  2022cites this paper
• The Tumor Microenvironment Reprograms Immune Cells

  2022cites this paper
• Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment

  2022cites this paper
• Comprehensive analysis of the amino acid metabolism-related gene signature for prognosis, tumor immune microenvironment, and candidate drugs in hepatocellular carcinoma

  2022cites this paper
• Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives

  2022cites this paper
• Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics

  2022cites this paper
• Nanoengineered drug delivery in cancer immunotherapy for overcoming immunosuppressive tumor microenvironment

  2022cites this paper
• Tumor-associated myeloid cells: diversity and therapeutic targeting

  2021cites this paper
• Altering Antigen Charge to Control Self-Assembly and Processing of Immune Signals During Cancer Vaccination

  2021cites this paper
• Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma

  2021cites this paper
• The relationship between the efficacy of talazoparib and the functional toll-like receptors 3 and 9 in triple negative breast cancer.

  2021cites this paper
• The impact of hypoxia on immune state in cancer.

  2021cites this paper
• Deciphering genes associated with diffuse large B-cell lymphoma with lymphomatous effusions: A mutational accumulation scoring approach

  2021cites this paper
• Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies

  2021cites this paper
• Unravelling the pro-tumorigenic role of innate immune pattern recognition receptors in the gastric compartment

  2021cites this paper
• Comprehensive Analysis of Innate Immunophenotyping Based on Immune Score Predicting Immune Alterations and Prognosis in Breast Cancer Patients

  2021cites this paper
• Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity

  2021cites this paper
• TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment

  2021cites this paper
• The Extracellular NADome Modulates Immune Responses

  2021cites this paper
• The Role of Toll-Like Receptor (TLR) Polymorphisms in Urinary Bladder Cancer

  2021cites this paper
• Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy

  2021cites this paper
• Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy

  2021cites this paper
• Toll-Like Receptor-Based Strategies for Cancer Immunotherapy

  2021cites this paper
• Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy.

  2021cites this paper
• Landscape of Toll-like receptors expression in tumor microenvironment of Triple Negative Breast Cancer (TNBC): distinct roles of TLR4 and TLR8.

  2021cites this paper
• Dissolving microneedles delivering cancer cell membrane coated nanoparticles for cancer immunotherapy

  2021cites this paper
• The isobaric tags for relative and absolute quantification-based quantitative proteomics of fresh tissue-derived secretome in hepatocellular carcinoma

  2021cites this paper
• Citric acid: A green cross-linker of biomaterials for biomedical applications

  2021cites this paper
• Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity

  2021cites this paper
• Innate Immune Response as a New Challenge in Periodontal Inflammation

  2021cites this paper
• Sex disparities matter in cancer development and therapy

  2021cites this paper
• CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change

  2021cites this paper
• Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy

  2021cites this paper